Study Section Problems

The commentaries on the problems of National Institutes of Health study sections by both Charles W. McCutchen [page 12] and Arthur E. Sowers [page 13] in the Oct. 16, 1995, issue of The Scientist were very insightful. The "kangaroo Politburos" problem is a major one and difficult to correct. I suggest an improvement. NIH should publicize study section openings. Then nominations for these positions should be held at a national meeting appropriate to each study section and voted on after discussi

Written byPeter Gouras
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Although not foolproof, this opens up the process to the scientific community and reduces concealed cronyism between powerful government agencies and influential cliques.

Other improvements can also be suggested, such as a similar exposure of government-directed non-R01 projects; ceilings on government funding to any one scientist or laboratory; the elimination of politically influenced center grants and merit awards; and more democratic control of NIH itself, in order to promote a greater diversification of ideas supportable and challengeable by the scientific community. An institute's goal should be to keep as many talented scientists as possible doing original research. Any compromise on this goal is misdirected.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies